(2S,3R,4S,6R)-4-amino-6-[2-(5,11-dimethylquinolino[2,3-b]indol-2-yl)oxyethoxy]-2-methyloxan-3-ol
Compound with spectra: 1 NMR
![(2S,3R,4S,6R)-4-amino-6-[2-(5,11-dimethylquinolino[2,3-b]indol-2-yl)oxyethoxy]-2-methyloxan-3-ol](/api/compound/DdVQoQg61da.png?ph=true&h=300&w=458 "(2S,3R,4S,6R)-4-amino-6-[2-(5,11-dimethylquinolino[2,3-b]indol-2-yl)oxyethoxy]-2-methyloxan-3-ol")
| SpectraBase Compound ID | DdVQoQg61da |
|---|---|
| InChI | InChI=1S/C25H29N3O4/c1-14-18-12-16(30-10-11-31-22-13-19(26)24(29)15(2)32-22)8-9-21(18)28(3)25-23(14)17-6-4-5-7-20(17)27-25/h4-9,12,15,19,22,24,29H,10-11,13,26H2,1-3H3/t15-,19-,22+,24-/m0/s1 |
| InChIKey | VMFRCPGXRMFIMY-QRFLKLNRSA-N |
| Mol Weight | 435.52 g/mol |
| Molecular Formula | C25H29N3O4 |
| Exact Mass | 435.215806 g/mol |
| Enantiomer InChIKey | VMFRCPGXRMFIMY-XPQXFEHLSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | DMSO-D6 |
(2S,3S,4S,6R)-4-amino-6-[5-(5,11-dimethylquinolino[2,3-b]indol-2-yl)oxypentoxy]-2-methyloxan-3-ol
LFURAYQVUIBSRP-UHFFFAOYSA-N
LINIRBCEAIIEOG-KLNIMBRESA-N
2-METHYL-11-TRIMETHYLSILYL-NEOCRYPTOLEPINE
OPCQZBJSWFSRJZ-UHFFFAOYSA-N
11-TRIMETHYLSILYL-NEOCRYPTOLEPINE
(2E)-6,7-dimethyl-2-[5-nitro-2,4-di(1-piperidinyl)benzylidene][1,3]thiazolo[3,2-a]benzimidazol-3(2H)-one
(2E)-2-[2,4-di(4-morpholinyl)-5-nitrobenzylidene]-6,7-dimethyl[1,3]thiazolo[3,2-a]benzimidazol-3(2H)-one
TORACHRYSONE-6-O-BETA-GENTIOBIOSYL-3-O-GLUCOPYRANOSYL-6-O-GLUCOPYRANOSIDE
N-METHOXYCARBONYL-3-EXO-(2-CHLORO-5-PYRIDYL)-2-ENDO-(PARA-TOLYLSULFONYL)-7-AZABICYCLO-[2.2.1]-HEPTANE
| Title | Journal or Book | Year |
|---|---|---|
| 1H and13C NMR data for indolo[2,3-b]quinoline–aminoglycoside hybrids, a novel potent anticancer drug family | Magnetic Resonance in Chemistry | 2006 |